Chapter 4 Flashcards
neurotransmitter
chemical released from the presynaptic axon terminal that serves as the basis of communication between neurons
- qualifications:
+ substance exists in presynaptic axon terminals
+ is synthesized in presynaptic cells
+ is released when action potentials reach axon terminals
+ receptors for the substance exist on postsynaptic membrane
+ when applied, substance produces changes in postsynaptic cells
+ blocking substance release prevents changes in postsynaptic cell
types of receptors
- ionotropic: fast; open an ion channel when the transmitter molecule binds; fast onset + decay (millisecond)
- metabotropic: slow; alter chemical reactions in the cell (e.g. G protein system) to open an ion channel; slower onset, long response and duration (second or minute)
ligand
substance that fit receptors exactly and activates or blocks them
- categories:
+ endogenous: produced inside the body (e.g. neurotransmitters and hormones)
+ exogenous: produced outside of body (e.g. drugs and toxins)
types of ligands
- agonist: initiates or activates the normal effects of the receptor
- antagonist: blocks the receptor from being activated by other ligands
- inverse agonist: initiates an effect that is the opposite of the normal function
drugs as exogenous ligands
- if act as agonists, antagonists or inverse agonists: COMPETITIVE ligands - bind to the same part of receptor molecule as endogenous ligands
- NONCOMPETITIVE ligands (also called neuromodulators): bind to modulatory sites that are not part of the receptor complex that normally binds the transmitter
types of neurotransmitters
- amine: acetylcholine, dopamine, norepinephrine, adrenaline, serotonin
- amino acid: GABA, glutamate
- peptide
- gas: nitric oxide, carbon dioxide
acetylcholine (ACh)
mapped by enzymes involved in synthesis; stored in cholinergic nerve cell bodies and projections
+ roles: signaling muscle movement, sensation of pain, learning + memory formation, regulation of endocrine system, sleep
dopamine (DA)
- found in substantia nigra of the mesostriatial pathway (in midbrain)
- role: motor control (neuronal loss in pathway leads to Parkinson’s disease) - found in ventral tegmental area (VTA) of the mesolimbocortical DA pathway (in midbrain)
- role: reward, reinforcement, and learning (abnormalities lead to schizophrenia & neurodegenerative diseases)
norepinephrine (NE)
also called noradrenaline
released in 3 brainstem regions: locus coeruleus (pons), lateral tegmental system (midbrain), and dorsal medullary group
- role: modulate processes of mood, arousal, and sexual behavior
serotonin (5-HT)
found in raphe nuclei
- role: sleep, mood, sexual behavior, anxiety
amino acid transmitters
- GABA: inhibitory - trigger IPSP
- glutamate: excitatory - trigger EPSP
+ excitotoxicity: neural injury such as stroke may cause excess release of glutamate, which is toxic to neurons
peptide
2+ amino acids linked in a chain; act as neurotransmitters or hormones
- opioid peptides: mimic opiate drugs (e.g. morphine)
- peptides in gut, spinal cord, or brain
- pituitary hormones
nitric oxide (NO)
produced in dendrites, diffuses as soon as it is produced into target cell and stimulates production of second messengers
mechanism of drugs
affect synaptic transmissions: either act on presynaptic terminals or postsynaptic membrane
- e.g. local anesthetics block sodium channels and therefore block action potentials in pain fibers
agonist vs. antagonist drugs
- agonist: initiates or activates normal effects of receptor
+ e.g. dopamine, morphine, nicotine - antagonist: blocks receptor from being activated by other ligands
+ e.g. haloperidol (treatment of schizophrenia)